The result from cBioPortal revealed that 6% (58/960) of BC exhibited ZNF132 alteration including missense mutation (2/960), amplification (19/960), deep deletion (6/960), mRNA upregulation (13/960) and mRNA downregulation (18/960) (Fig. 3a). Here, ZNF132 is linked to breast cancer.